Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Classification of Illness01:17

Classification of Illness

8.3K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.3K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

piR-LGBM: A Sparse Autoencoder-Enhanced Gradient Boosting Framework to Uncover Disease-Associated piRNAs.

Omics : a journal of integrative biology·2026
Same author

A systematic study of parameter sharing strategies in multi-task learning for drug synergy and sensitivity prediction.

Journal of computer-aided molecular design·2026
Same author

A deep drug prediction framework for viral infectious diseases using an optimizer-based ensemble of convolutional neural network: COVID-19 as a case study.

Molecular diversity·2024
Same author

An ensemble approach for circular RNA-disease association prediction using variational autoencoder and genetic algorithm.

Journal of bioinformatics and computational biology·2024
Same author

Identification of gene-level methylation for disease prediction.

Interdisciplinary sciences, computational life sciences·2023
Same author

Blood-based gene-expression biomarkers identification for the non-invasive diagnosis of Parkinson's disease using two-layer hybrid feature selection.

Gene·2022

Related Experiment Video

Updated: Dec 1, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.5K

Inferring Potential CircRNA-Disease Associations via Deep Autoencoder-Based Classification.

K Deepthi1,2, A S Jereesh3

  • 1Bioinformatics Lab, Department of Computer Science, Cochin University of Science and Technology, Kochi, Kerala, 682022, India. deepthi523@gmail.com.

Molecular Diagnosis & Therapy
|November 6, 2020
PubMed
Summary

Researchers developed a new computational tool called AE-RF to predict links between circular RNAs and various human diseases. By combining deep learning with traditional classification techniques, the model identifies potential disease-related markers more efficiently than previous methods. This approach helps prioritize candidates for future laboratory testing, saving time and resources.

Keywords:
Computational BiologyMachine LearningDisease PredictionNon-coding RNA

Frequently Asked Questions

More Related Videos

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

1.8K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.1K

Related Experiment Videos

Last Updated: Dec 1, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.5K
In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

1.8K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.1K

Area of Science:

  • Bioinformatics and computational biology research involving circRNA-disease associations
  • Genomics and molecular pathology within systems biology

Background:

No prior work had fully resolved how to efficiently predict links between circular RNAs and complex human pathologies. It was already known that these non-coding molecules possess unique, stable circular structures. Prior research has shown that abnormal expression levels of these transcripts often correlate with various medical conditions. That uncertainty drove the need for faster identification methods beyond traditional wet-lab experiments. This gap motivated the development of predictive models to screen large biological datasets. Previous studies struggled with the high costs and slow pace of standard laboratory validation. Researchers required more robust tools to handle the complexity of these molecular interactions. This paper addresses the challenge by leveraging advanced machine learning architectures for better association mapping.

Purpose Of The Study:

The study aims to develop a robust computational method for identifying potential associations between circular RNAs and complex diseases. This research addresses the significant challenges posed by the time-consuming and expensive nature of traditional biological experiments. The authors seek to overcome the limitations of existing predictive tools by introducing an ensemble approach. They propose a framework that leverages deep learning to extract hidden patterns from biological data. By integrating similarity metrics, the researchers intend to improve the accuracy of association mapping. The motivation stems from the need to prioritize candidates for further laboratory validation in a more efficient manner. This work focuses on creating a model that can handle the complexity of molecular interactions more effectively than previous techniques. Ultimately, the team strives to provide a reliable computational strategy to accelerate the discovery of disease-related markers.

Main Methods:

Review approach involved designing an ensemble framework that combines deep learning with traditional classification algorithms. The team first constructed a comprehensive feature set by integrating similarity data from both circular RNAs and diseases. These integrated inputs were then processed through a deep autoencoder to uncover latent biological representations. The researchers utilized the resulting deep features to train a random forest classifier for association prediction. This design choice aimed to capture complex, non-linear relationships within the biological data. The study implemented fivefold and tenfold cross-validation protocols to rigorously evaluate the model's predictive capabilities. To demonstrate effectiveness, the team compared their results against several state-of-the-art classifiers and existing computational methods. Finally, the investigators performed case studies on three common human cancers to validate the practical utility of the top-ranked predictions.

Main Results:

Key findings from the literature reveal that the AE-RF model achieved an area under the curve score of 0.9486 during fivefold cross-validation. In tenfold cross-validation experiments, the framework reached a higher score of 0.9522. The results demonstrate that training the classifier with unique features retrieved by the autoencoder significantly enhanced predictive performance. The model outperformed existing state-of-the-art classifiers and related methods in terms of overall accuracy. Case studies focused on three common human cancers confirmed the practical relevance of the top-most predicted results. The authors report that the system exhibits a high degree of robustness across different testing scenarios. These findings indicate that the integrated approach effectively identifies potential disease-associated molecules. The data suggest that the top predicted candidates are highly promising for further biological investigation.

Conclusions:

The authors suggest their ensemble framework provides a reliable way to prioritize candidates for future experimental validation. Synthesis and implications indicate that integrating similarity metrics enhances the overall predictive capacity of the model. The researchers propose that their deep learning architecture successfully captures hidden patterns within complex biological data. Their findings imply that utilizing autoencoders for feature extraction significantly improves performance over standard classification approaches. The study demonstrates that the proposed method maintains high robustness when compared against existing state-of-the-art techniques. Authors highlight that the top-ranked predictions serve as promising targets for subsequent clinical or laboratory investigation. The evidence suggests that computational screening effectively narrows the search space for identifying disease-linked molecules. Finally, the work confirms that combining deep learning with random forest classifiers offers a powerful strategy for association discovery.

The researchers propose an ensemble framework, AE-RF, which utilizes a deep autoencoder for feature extraction followed by a random forest classifier. This architecture identifies hidden biological patterns to predict potential links between circular RNAs and various human pathologies.

The model integrates similarity metrics from both circular RNAs and diseases to construct initial features. These inputs are subsequently processed by the deep autoencoder to generate refined representations for the downstream classification task.

A deep autoencoder is necessary to extract latent biological patterns from the integrated similarity data. This step allows the system to identify complex relationships that might be missed by simpler, linear modeling approaches.

The autoencoder transforms raw similarity data into unique, high-level features. These representations are essential for the random forest classifier to achieve superior predictive accuracy compared to models relying on unprocessed input data.

The model achieved area under the curve scores of 0.9486 and 0.9522 during fivefold and tenfold cross-validation experiments, respectively. These metrics indicate higher predictive performance than state-of-the-art classifiers used in previous studies.

The authors propose that their computational approach significantly reduces the time and expense required for biological discovery. They suggest that their method provides a robust foundation for prioritizing candidates for future laboratory testing.